Source tracing of chromium-, manganese-, nickel- and zinc-containing particles (PM<Subscript>10</Subscript>) by micro-PIXE spectrum

Due to the interesting anti-proliferative properties of gallium-thiosemicarbazone complexes, the production of [⁶⁷Ga]labeled 2-acetylpyridine 4,4-dimethyl thiosemicarbazone (APTSM₂) was investigated. The freshly prepared [⁶⁷Ga]GaCl₃ was mixed with 2-acetylpyridine 4,4-dimethyl thiosemicarbazone for 60 minutes at 90 °C to yield [⁶⁷Ga]APTSM₂ with a radiochemical yield of more than 98%. Radio-thin-layer-chromatography (RTLC) showed a radiochemical purity of more than 99%. A specific activity of about 370–740 MBq/mmol (10–20 Ci/mmol) was obtained. The stability of the final product was checked in the absence and presence of human serum at 37 °C. The partition coefficient of the final complex was also determined. The biodistribution of the labeled compound in normal rats was compared with that of free Ga³⁺ cation up to 22 hours.     

Development and evaluation of a 166holmium labelled porphyrin complex as a possible therapeutic agent

Porphyrins are interesting derivatives with low toxicity, tumor avidity and rapid wash-out suggested as potential radiopharmaceuticals in radiolabeled form. In this work, [¹⁶⁶Ho] labeled 5,10,15,20-tetrakis(phenyl) porphyrin ([¹⁶⁶Ho]-TPP) was prepared using [¹⁶⁶Ho]HoCl₃ and 5,10,15,20-tetrakis(phenyl)porphyrin (H₂TPP) for 12 h at 50 °C (radiochemical purity: >95 ± 2 % ITLC, >99 ± 0.5 % HPLC, specific activity: 0.9–1.1 GBq/mmol). Stability of the complex was checked in final formulation and human serum for 48 h. The partition coefficient was calculated for the compound (log P = 2.01). The biodistribution of the labeled compound in vital organs of wild-type rats was studied using scarification studies and SPECT. A detailed comparative pharmacokinetic study performed for ¹⁶⁶Ho cation and [¹⁶⁶Ho]-TPP performed up to 24 h. The complex is mostly washed out from the circulation through kidneys and in less extends from the liver. The kidney:blood, kidney:liver and kidney:muscle ratios 4 h post injection were 14, 3.6 and 7.38 respectively.     

Development of <Superscript>177</Superscript>Lu-DOTA-anti-CD20 for radioimmunotherapy

Rituximab was successively labeled with ¹⁷⁷Lu-lutetium chloride. ¹⁷⁷Lu chloride was obtained by thermal neutron flux (4 × 10¹³ n cm⁻² s⁻¹) of natural Lu₂O₃ sample with a specific activity of 2.6–3 GBq/mg. The macrocyclic bifunctional chelating agent, N-succinimidyl-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA-NHS) was prepared at 25 °C using DOTA, N-hydroxy succinimide (NHS) in CH₂Cl₂. DOTA-rituximab was obtained by the addition of 1 mL of a rituximab pharmaceutical solution (5 mg/mL, in phosphate buffer, pH 7.8) to a glass tube pre-coated with DOTA-NHS (0.01–0.1 mg) at 25 °C with continuous mild stirring for 15 h. Radiolabeling was performed at 37 °C in 24 h. Radio-thin layer chromatography showed an overall radiochemical purity of >98% at optimized conditions (specific activity = 444 MBq/mg, labeling efficacy; 82%). The final isotonic ¹⁷⁷Lu-DOTA-rituximab complex was checked by gel electrophoresis for structure integrity control. Radio-TLC was performed to ensure that only one species was present after filtration through a 0.22 μm filter. Preliminary biodistribution studies in normal rats were carried out to determine complex distribution of the radioimmunoconjugate up to 168 h. The biodistribution data were in accordance with other antiCD20 radioimmunoconjugates already reported.     

Development of radiogallium–ethylenecysteamine cysteine complex as a possible renal imaging agent

[⁶⁷Ga]-ethylenecysteamine cysteine ([⁶⁷Ga]ECC) was prepared using freshly prepared [⁶⁷Ga]GaCl₃ and ethylenecysteamine cysteine (ECC) for 30 min at 90 °C (radiochemical purity ≈97 ± 0.88% ITLC, specific activity: 210 ± 5 GBq/mM). Stability of the complex was checked in human serum for 24 h at 37 °C. Partition co-efficient of the tracer in octanol:saline mixture was determined (log P; 0.8). The biodistribution of the radiolabeled compound in vital organs of wild-type rats were compared with that of free Ga³⁺ cation up to 48 h. Initial biodistribution results showed significant kidney excretion of the tracer comparable to that of homologous ^99mTc compound.     

Separation of radioarsenic from irradiated germanium oxide targets for the production of <Superscript>71</Superscript>As and <Superscript>72</Superscript>As

A method for the separation of no-carrier-added arsenic radionuclides from the bulk amount of proton-irradiated GeO₂ targets as well as from coproduced radiogallium was developed. The radionuclides ⁶⁹Ge and ⁶⁷Ga produced during irradiation of GeO₂ were used as tracers for Ge and Ga in the experiments. After dissolution of the target the ratio of As(III) to As(V) was determined via thin layer chromatography (TLC). The extraction of radioarsenic by different organic solvents from acid solutions containing alkali iodide was studied and optimized. The influence of the concentration of various acids (HCl, HClO₄, HNO₃, HBr, H₂SO₄) as well as of KI was studied using cyclohexane. The optimum separation of radioarsenic was achieved using cyclohexane with 4.75 M HCl and 0.5 M KI and its back-extraction with a 0.1% H₂O₂ solution. The separation leads to high purity radioarsenic containing no radiogallium and <0.001% [⁶⁹Ge]Ge. The overall radiochemical yield is 93 ± 3%. The practical application of the optimized procedure in the production of ⁷¹As and ⁷²As is demonstrated and batch yields achieved were in the range of 75–84% of the theoretical values.     

Reactions of [Cp*Ru(H<Subscript>2</Subscript>O)(NBD)]<Superscript>+</Superscript> with diynes

Abstract  Formal [2 + 2 + 2] addition reaction of [Cp*Ru(H₂O)(NBD)][BF₄] (NBD = norbornadiene) with 4,4′-Diethynylbiphenyl generates [C₉H₉-η⁶-C₆H₄(RuCp*)–C₆H₄(RuCp*)-η⁶-C₉H₉][BF₄]₂. The reaction of [Cp*Ru(H₂O)(NBD)][BF₄] with 1,4-diphenylbutadiyne generates the unusual [2 + 2 + 2] additional organic compound Ph–C≡C–C₉H₈–Ph in addition to the organometallic compound [Cp*Ru(η⁶-C₆H₅–C≡C–C≡C–Ph)][BF₄]. [C₉H₉-η⁶-C₆H₄(RuCp*)–C₆H₄(RuCp*)-η⁶-C₉H₉][BPh₄]₂ is generated after the reaction of compound [C₉H₉-η⁶-C₆H₄(RuCp*)–C₆H₄(RuCp*)-η⁶-C₉H₉][BF₄]₂ with Na[BPh₄]. The structure of this compound was confirmed by X-ray diffraction. A possible approach to form Ph–C≡C–C₉H₈–Ph and [Cp*Ru(η⁶-C₆H₅–C≡C–C≡C–Ph)][BF₄] is suggested. Graphical Abstract  Formal [2 + 2 + 2] addition reaction of [Cp*Ru(H₂O)(NBD)]BF₄ (NBD = norbornadiene) with 4,4′-Diethynylbiphenyl generates [C₉H₉-η⁶-C₆H₄(RuCp*)–C₆H₄(RuCp*)-η⁶-C₉H₉][BF₄]₂. The reaction of [Cp*Ru(H₂O)(NBD)][BF₄] with 1,4-diphenylbutadiyne simply generates unusual [2 + 2 + 2] additional organic compound Ph–C≡C–C₉H₈–Ph in addition to the organometallic compound [Cp*Ru(η⁶-C₆H₅–C≡C–C≡C–Ph)][BF₄]. [C₉H₉-η⁶-C₆H₄(RuCp*)–C₆H₄(RuCp*)-η⁶-C₉H₉][BPh₄]₂ is generated after the reaction of compound [C₉H₉-η⁶-C₆H₄(RuCp*)–C₆H₄(RuCp*)-η⁶-C₉H₉][BF₄]₂ with Na[BPh₄]. The structure of this compound was confirmed by X-ray diffraction. And the possible approach to form Ph–C≡C–C₉H₈–Ph and [Cp*Ru(η⁶-C₆H₅–C≡C–C≡C–Ph)][BF₄] was suggested. Electronic supplementary material  The online version of this article (doi:) contains supplementary material, which is available to authorized users.     

Development of [<Superscript>64</Superscript>Cu]-DOTA-anti-CD20 for targeted therapy

Copper-64 was produced as a by-product of ⁵⁵Co via ⁶⁴Ni(p,n)⁶⁴Cu by 15 MeV proton bombardment of ^natNi resulting in a thick target yield of 5.31 MBq/μAh (143.5 μCi/μAh) and a radiochemical separation yield of 95% (radionuclide purity >97% after 25 hours of bombardment). Rituximab was successively labeled with [⁶⁴Cu]-CuCl₂. N-succinimidyl-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA-NHS) was prepared at 25 °C using DOTA and N-hydroxy succinimide (NHS) in CH₂Cl₂ followed by the addition of 1 ml of a Rituximab pharmaceutical solution. Radiolabeling was performed at 37 °C in 3 hours. Radio thin-layer chromatography showed an overall radiochemical purity of 90–95% at optimized conditions (specific activity=30 GBq/mg, labeling efficacy; 82%) using various chromatography systems. The final isotonic ⁶⁴Cu-DOTA-Rituximab complex was passed through a 0.22 μm filter and checked by gel electrophoresis for radiolysis control. Stability of the final product was checked in the formulation and in presence of human serum at 37 °C.     

Pyridyl derivatives provide new pathways for labeling protein with fac-[<Superscript>188</Superscript>Re(CO)<Subscript>3</Subscript>(H<Subscript>2</Subscript>O)<Subscript>3</Subscript>]<Superscript>+</Superscript>

The purpose of this work was to indirect label IgG with fac-[¹⁸⁸Re(CO)₃(H₂O)₃]⁺ and to check the radiochemical behavior of the labeled product. The compound of (bis(2-pyridylmethyl)-amino)-acetic acid (L²H) was synthesized and labeled with fac-[¹⁸⁸Re(CO)₃(H₂O)₃]⁺. The labeling yield of ¹⁸⁸Re(CO)₃–L²H was more than 90%. The effects of protein concentration, reaction time, pH and reaction temperature of labeling of IgG with ¹⁸⁸Re(CO)₃–L²H were investigated. The conjugation conditions were optimized. The labeled product was analyzed by size exclusion HPLC and TLC. The stability of ¹⁸⁸Re(CO)₃–L²H–IgG in vitro was high. The results of this study may be useful for [¹⁸⁸Re(CO)₃(H₂O)₃]⁺ labeling of protein for radioimmunotherapy.     

Nucleophilic aromatic substitution by [<Superscript>18</Superscript>F]fluoride at substituted 2-nitropyridines

For the radiofluorination of benzenes and benzene derivatives, the electrophilic reaction with [¹⁸F]F₂ is a very common route. Yet, aromatic nucleophilic substitution (S_NAr) by n.c.a [¹⁸F]fluoride, which can be produced efficiently in high amounts, has been considered to be very desirable. However, to facilitate ¹⁸F-labelling via S_NAr at an electron rich aromatic system, an appropriate leaving group must be present together with an auxiliary group in ortho or para position to the leaving group. An interesting alternative for the auxiliary group is the heteroatom of a heteroaromatic system, for which pyridine is a leading example. Dolci et al. (J Label Compd Radiopharm 42:975–985, 1999) have evaluated the scope of the nucleophilic aromatic fluorination of 2-substituted pyridine rings using the activated K [¹⁸F]F-K₂₂₂ complex. As methyl and methoxy groups are known to enhance the electron density of an aromatic system by the +I and the +M effect, respectively, S_NAr is unlikely to occur. Until now, the effect of these substituents has not been studied towards the ¹⁸F-radiofluorination of substituted 2-nitropyridines by use of [¹⁸F]fluoride. Therefore, we have investigated the effect of methoxy and methyl groups in 2-nitropyridines. The results showed that 3-methoxy-2-nitropyridine and 3-methyl-2-nitropyridine can efficiently be substituted by [¹⁸F]fluoride with high RCY’s (70–89%) in short reaction times (1–30 min) at a reaction temperature of 140 °C. Moreover, 3-methoxy-6-methyl-2-[¹⁸F]fluoropyridine was obtained from the corresponding nitro-precursor in a high yield of 81 ± 1% after 30 min at 140 °C. In case of 2-nitropyridines data indicates the effect of methyl and methoxy groups on S_NAr to be of minor importance.     

Reduction of <Superscript>68</Superscript>Ge activity containing liquid waste from <Superscript>68</Superscript>Ga PET chemistry in nuclear medicine and radiopharmacy by solidification

PET with ⁶⁸Ga from the TiO₂- or SnO₂- based ⁶⁸Ge/⁶⁸Ga generators is of increasing interest for PET imaging in nuclear medicine. In general, radionuclidic purity (⁶⁸Ge vs. ⁶⁸Ga activity) of the eluate of these generators varies between 0.01 and 0.001%. Liquid waste containing low amounts of ⁶⁸Ge activity is produced by eluting the ⁶⁸Ge/⁶⁸Ga generators and residues from PET chemistry. Since clearance level of ⁶⁸Ge activity in waste may not exceed 10 Bq/g, as stated by European Directive 96/29/EURATOM, our purpose was to reduce ⁶⁸Ge activity in solution from >10 kBq/g to <10 Bq/g; which implies the solution can be discarded as regular waste. Most efficient method to reduce the ⁶⁸Ge activity is by sorption of TiO₂ or Fe₂O₃ and subsequent centrifugation. The required 10 Bq per mL level of ⁶⁸Ge activity in waste was reached by Fe₂O₃ logarithmically, whereas with TiO₂ asymptotically. The procedure with Fe₂O₃ eliminates ≥90% of the ⁶⁸Ge activity per treatment. Eventually, to simplify the processing a recirculation system was used to investigate ⁶⁸Ge activity sorption on TiO₂, Fe₂O₃ or Zeolite. Zeolite was introduced for its high sorption at low pH, therefore ⁶⁸Ge activity containing waste could directly be used without further interventions. ⁶⁸Ge activity containing liquid waste at different HCl concentrations (0.05–1.0 M HCl), was recirculated at 1 mL/min. With Zeolite in the recirculation system, ⁶⁸Ge activity showed highest sorption.     

Preparation, nano purification, quality control and labeling optimization of [64Cu]-5,10,15,20-tetrakis (penta fluoro phenyl) porphyrin complex as a possible imaging agent

Cu-64 was produced via the ⁶⁸Zn (p,αn)⁶⁴Cu nuclear reaction (≈200 mCi, >95 % chemical yield at 180 μA for 1.1 h irradiation, (radionuclidic purity >96 %, copper-67 as impurity) followed by purification with amino functionalized nano magnetic oxide, Fe₃O₄ aiming to remove trace amount of heavy metal ions from aqueous media due to achieve ultra pure [⁶⁴Cu] CuCl₂ for labeling step. [⁶⁴Cu] labeled 5,10,15,20-tetrakis(penta fluoro phenyl) porphyrin ([⁶⁴Cu]-TFPP) was prepared using freshly prepared [⁶⁴Cu] CuCl₂ (Cu-64; T _1/2 = 12.7 h) and 5,10,15,20-tetrakis(penta fluoro phenyl)porphyrin (H₂TFPP) for 60 min at 100 °C under reflux condition (radiochemical purity: >97 % ITLC, >98 % HPLC, specific activity: 14–16 GBq/mmol). Stability of the complex was checked in final formulation and human serum for 24 h. The partition coefficient was calculated for the compound (log P = 0.73). The biodistribution of the labeled compound in vital organs of wild-type rats was studied using scarification studies and PET imaging up in 2 and 4 h after injection. A detailed comparative pharmacokinetic study performed for ⁶⁴Cu cation and [⁶⁴Cu]-TFPP. The complex is mostly washed out from the circulation through kidneys and liver and can be an interesting tumor imaging/targeting agent due to high specific uptake and rapid excretion through the urinary tract.     

Preparation of [<Superscript>66</Superscript>Ga]bleomycin complex as a possible PET radiopharmaceutical

Summary Gallium-66 (T_1/2 = 9.49 h) is an interesting radionuclide that has potential use for positron emission tomography (PET) imaging of biological processes in intermediate to slow target tissue uptake. ⁶⁶Ga was produced in the NRCAM cyclotron as a result of 15 MeV proton bombardment of ⁶⁶Zn with current intensity of 180 μA (yield 11.2 mCi/μAh). Bleomycin (BLM) was labeled with [⁶⁶Ga]GaCl₃     

Radiofluorination of 2-fluoropyridines by isotopic exchange with [<Superscript>18</Superscript>F]fluoride

In homoaromatic systems, isotopic exchange (¹⁸F/¹⁹F) was previously (J Label Compd Radiopharm 18(12):1721–1730 [2], J Chem Soc Perkin Trans 1(3):295–298 [3]) proven to be advantageous, yet in general specific activity is thought to be low. For heteroaromatic systems, in particular, very few examples are published regarding the ¹⁸F-labelling of 2-substituted pyridines (J Label Compd Radiopharm 42:975–985 [9]). Therefore, in 2-fluoropyridines, we decided to study the ¹⁸F labelling by isotopic exchange (¹⁸F/¹⁹F). The radiochemical yield for 2-fluoropyridine was 90 ± 2%. Even if 2-fluoropyridine was substituted by an electron-donating group such as a methyl or a methoxy group, radiochemical yields were 80 ± 1 and 78 ± 1%, respectively. Although in benzenes, these substituents are known to decrease nucleophilic substitutions by ¹⁸F-Fluoride significantly. Moreover, by choosing appropriate concentrations of 2-fluoropyridines, reasonably high specific activities up to 10 GBq/μmol were obtained.     

A perspective on <Superscript>99m</Superscript>Tc and <Superscript>125/131</Superscript>I labeled receptor targeted compounds and their in vitro/in vivo affinities

A novel quinoline derivative, 2,2′-[(5-chloro-8-hydroxyquinoline-7-yl) methylazanediyl] diacetic acid (CHQMADA) was labeled with ^99mTc using SnCl₂·2H₂O as a reducing agent to give a complex with a labeling yield 94 %. Also [^99mTc(H₂O)₃(CO)₃]⁺ was prepared by heating at 100 °C for 30 min using 2 mg CHQMADA at pH 8 to give a labeling yield >99 %. ^99mTc-(CO)₃ CHQMADA and ^99mTc-Sn(II)-CHQMADA showed tissue uptake (target to non target T/NT = 6.80 ± 0.22) and (T/NT = 5.65 ± 0.34) respectively in Escherichia coli induced infection, which is higher than the commercially available ^99mTc-ciprofloxacin (T/NT = 3.80 ± 0.80). In conclusion, both complexes were able to differentiate between septic and aseptic inflammation with superiority of [^99mTc-(CO)₃ CHQMADA].     

Development of an in vivo radionuclide generator by labeling bleomycin with <Superscript>191</Superscript>Os

Bleomycin (BLM) has been labeled with various radioisotopes and widely used in therapy and diagnosis. ¹⁹¹Os is a parent radionuclide with 15.4 day half-life and decays by beta emission to ^191mIr, which is a radionuclide with 4.96 s half-life. BLM was labeled with ¹⁹¹Os-hexachloro-osmate and its distribution and stability in wild-type mice was determined. The complex was obtained at the pH 2 in normal saline at 90 °C in 48 h. Radio-TLC showed an overall radiochemical yield of 93–97%, radio-chemical purity > 97%. The biodistribution study for ¹⁹¹Os-hexachloro-osmate and ¹⁹¹Os-BLM were carried in wild type-mice up to 14 days. Lungs, liver and spleen uptake increased 24–72 h after administration of ¹⁹¹Os-BLM. 24 h after administration, the radioactivity of the kidney increased and remained constant.     

Industrial production and purification of <Superscript>32</Superscript>P by sulfur irradiation with partially moderated neutron fluxes and target melting

Target purification of S_α is carried out by distillation at 444±2 °C under N atmosphere and diluting the vapors in CS₂. The solution is filtered through fiberglass, Teflon and cellulose to obtain S_α by CS₂ evaporation. Once 30 g of this target are irradiated with fast neutron fluxes from 4.5 to 7.4·10¹² n·cm⁻²s⁻¹ from 6 to 12 hours, the nuclear reaction ³²S(n,p)³²P takes place. So, the irradiated S_α sample is placed in a Pyrex container situated inside a furnace as the most important piece of equipment in one aluminum and Lucite glove box. The distillation of irradiated sulfur takes place at 444±2 °C under N atmosphere during 1–2 hours. The vapors are connected to a sulfur diluter containing 20% CS₂ aqueous solution, followed by an activated carbon filter and the two similar additional sulfur diluters. Once cooled, the distillation chamber keeps the radioactive, carrier-free ³²P stuck to the wall. Then 25–50 ml of 0.1N HCl acid was injected by suction and heated again at 110±2 °C during 1 hour. The corresponding chemical reaction takes place and the labeled H₃ ³²PO₄ solution is produced. In such a way, industrial production of ³²P labeled molecules has started in Mexico, with an initial production of 3700–5550 MBq per week.     

Preparation of <Superscript>99m</Superscript>Tc-PQQ and preliminary biological evaluation for the NMDA receptor

Pyrroloquinoline quinone (PQQ), an essential nutrient, antioxidant, redox modulator and nerve growth factor found in a class of enzymes called quinoproteins, was labeled with ^99mTc by using stannous fluoride (SnF₂) method. Radiolabeling qualification, quality control and characterization of ^99mTc-PQQ and its biodistribution studies in mice were performed and discussed. Effects of pH values, temperature, time and reducing agents concentration on the radiolabeling yield were investigated. The quality control procedure of ^99mTc-PQQ was determined by thin layer chromatography (TLC), radio high-performance liquid chromatography (RHPLC) and paper electrophoresis methods. The average radiolabeling yield was 94 ± 1% under optimum conditions of 0.99 mg of PQQ, 30 μg of SnF₂, 0.5 mg of ethylenediaminetetraacetic acid disodium salt (EDTA-2Na) and 18.5 MBq of Na^99mTcO₄ at pH 6 and 25 °C with a response volume of 1 ± 0.1 mL. ^99mTc-PQQ was stable and anionic. Lipid–water partition coefficient of ^99mTc-PQQ was −1.49 ± 0.16. The pharmacokinetics parameters of ^99mTc-PQQ were t _1/2α = 18.16 min, t _1/2β = 100.45 min, K ₁₂ = 0.013 min⁻¹, K ₂₁ = 0.017 min⁻¹, K _e = 0.016 min⁻¹, AUC (area under the curve) = 1040.78 ID% g⁻¹ min and CL (plasma clearance) = 0.096 mL min⁻¹. The dual-exponential equation was Y = 10.88e^−0.038t  + 5.21e^−0.0069t . The biodistribution of ^99mTc-PQQ was studied in ICR (Institute for Cancer Research 7701 Burhelme Are., Fox Chase, Philadelphia, PA 1911 USA) mice. In vitro autoradiographic studies clearly showed that the ^99mTc-PQQ radioactivity accumulated predominantly in the hippocampus and cortex, which had a high density of N-methyl-d-aspartate Receptor (NMDAR). The enrichment can be blocked by NMDAR redox modulatory site antagonists-ebselen (EB) and ^99mTc-PQQ is therefore a promising candidate for the molecular imaging of NMDAR. To date, however, there have been no studies characterizing ^99mTc-PQQ.     

Determination of activity ratios of <Superscript>238,239+240,241</Superscript>Pu, <Superscript>241</Superscript>Am, <Superscript>134,137</Superscript>Cs,and <Superscript>90</Superscript>Sr in Bulgarian soils

The origins of different artificial radionuclides found in soils from Northern and Southern Bulgaria was determined by measurements of their actual concentrations and respective ratios. On the basis of the measured mobility and concentrations of the investigated radionuclides in soils, it was estimated that after the Chernobyl accident the mean depositions of fresh ¹³⁷Cs were 3.0 ± 2.5 kBq/m² for Northern Bulgaria and 15 ± 7 kBq/m² for Southern Bulgaria. As a result of global fallout following atmospheric nuclear weapon tests in the 1950s, mean depositions (corrected to 1965) were calculated for Northern and Southern Bulgaria as follows: for ⁹⁰Sr—1.0 ± 0.5 and 2.3 ± 1.3 kBq/m², ²³⁸Pu—1.3 ± 0.8 and 2.8 ± 1.6 Bq/m², ^239+240Pu—15 ± 14 and 47 ± 38 Bq/m², and ²⁴¹Pu—520 ± 200 and 760 ± 260 Bq/m².     

Extraction of metal ions (Fe<Superscript>3+</Superscript>, Co<Superscript>2+</Superscript>, Ni<Superscript>2+</Superscript>, Cu<Superscript>2+</Superscript> and Zn<Superscript>2+</Superscript>) using immobilized-polysiloxane iminobis(n-2-aminophenylacetamide) ligand system

A new insoluble solid functionalized ligand system bearing chelating ligand group of the general formula P-(CH₂)₃-N[CH₂CONH(C₆H₄)NH₂]₂, where P represents [Si–O] _n polysiloxane network, was prepared by the reaction of the immobilized diethyliminodiacetate polysiloxane ligand system, P-(CH₂)₃N(CH₂CO₂Et)₂ with 1,2-diaminobenzene in toluene. ¹³C CP-MAS NMR, XPS and FTIR results showed that most ethylacetate groups (–COOEt) were converted into the amide groups (–N–C=O). The new functionalized ligand system exhibits high capacity for extraction and removal of the metal ions (Fe³⁺, Co²⁺, Ni²⁺, Cu²⁺ and Zn²⁺) with efficiency of 95–97% after recovery from its primary metal complexes. This functionalized ligand system formed 1:1 metal to ligand complexes.     

Synthesis and evaluation of a new bombesin analog labeled with <Superscript>99m</Superscript>Tc as a GRP receptor imaging agent

Tumors such as prostate, small cell lung cancer, breast, gastric and colon cancer are known to overexpress receptors to bombesin (BBN). In this study, a new bombesin analogue was labeled with ^99mTc via HYNIC and tricine/EDDA as coligands and investigated further. HYNIC-GABA-Bombesin (7–14) NH₂ was synthesized using a standard Fmoc strategy. Labeling with ^99mTc was performed at 100 °C for 10 min and radiochemical analysis involved ITLC and HPLC methods. The stability of radiopeptide was checked in the presence of humane serum at 37 °C up to 24 h. The receptor bound internalization and externalization rates were studied in GRP receptor expressing PC-3 cells. Biodistribution of radiopeptide was studied in nude mice bearing PC-3 tumor. Labeling yield of >98% was obtained corresponding to a specific activity of ~2.6 MBq/nmol. Peptide conjugate showed good stability in the presence of human serum. The radioligand showed high and specific internalization into PC-3 cells (14.63 ± 0.41% at 4 h). In biodistribution studies, a receptor-specific uptake was observed in GRP-receptor-positive organs so that after 4 h the uptakes in mouse tumor and pancreas were 1.31 ± 0.18 and 1.2 ± 0.13% ID/g, respectively.